Abstract
The origin of induced changes in the peripheral blood frequently resides in the bone marrow. Although interim (within study) canine bone marrow analysis provides crucial and vital information supplementary to such changes, it is not a routine technique in normal toxicity studies. A two-tiered approach is reasonable and scientifically justified, with haemocytometry as the first tier, and interim bone marrow analysis as the second, only to be performed if indicated by peripheral blood values.
Additionally, ethical and economic reasons play a decisive role in not performing interim canine marrow sampling on a routine basis, but only on selected occasions. Such an occasion would be the presence of a thrombocytopenia, where an objective assessment of megakaryoblast/megakaryocyte numbers and morphology would be a distinct advantage in determining the aetiology of the condition. However, such evaluations are normally hampered by the relatively small numbers of these cells, and a method for overcoming this problem is described.
Similar content being viewed by others
References
Burstein SA, Friese P, Downs T et al. (1991) Canine megakaryopoiesis: analysis using a monoclonal antibody to a 140-kd dog platelet protein. Exp Hematol 19:47–52
Choi ES, Nichol J, Hokom M et al. (1995) Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85:402–413
Darbes J, Colbatzky F, Minkus G et al. (1993) Demonstration of feline and canine platelet glycoproteins by immuno- and lectin histochemistry. Histochemistry 100:83–91
Emmons R, Reid D, Cohen R et al. (1996) Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068–4071
Groopman JE, Molina JM, Scadden DT (1989) Hematopoietic growth factors: biology and clinical applications. N Engl J Med 321:1449–1459
Jackson CW, Brown LK, Somerville BC et al. (1984) Two-colour flow cytometric measurements of DNA distributions of rat megakaryocytes in unfixed, unfractionated marrow cell suspensions. Blood 63:768–778
Jain, NC (1986) Schalm's veterinary hematology, 4th edn. Lea and Febiger, Philadelphia
Keller P, Freudiger U (1983) Atlas of hematology of the dog and cat. Verlag Paul Parey, Berlin and Hamburg
Kobayashi Y, Ozawa M, Maruo N (1989) Microcytofluorometrical measurement of DNA content in immunologically identified micromegakaryocytes of human bone marrow. Acta Haematol Japan 52:1165–1169
McDonald TP, Jackson CW (1994) Mode of inheritance of the higher degree of megakaryocyte polyploidization in C3H mice. Blood 83:1493–1498
Nagasawa T, Hasegawa Y, Kamoshita M et al. (1995) Megakaryopoiesis in patients with cyclic thrombocytopenia. Br J Haematol 91:185–190
Sullivan PS, Manning KL, McDonald TP (1995) Association of mean platelet volume and bone marrow megakaryocytopoiesis in thrombocytopenic dogs. J Am Vet Med Assoc 206:332–334
Tomer A, Harker LA, Burstein SA (1987) Purification of human megakaryocytes by fluorescence-activated cell sorting. Blood 70:1735–1742
Tomer A, Harker LA, Burstein SA (1988) Flow cytometric analysis of normal human megakaryocytes. Blood 71:1244–1252
Topps KS, Tablin F, Levin J (1990) Culture of isolated bovine megakaryocyte on reconstituted basement membrane matrix leads to proplatelet process formation. Blood 76:912–924
Warheit DB, Salley SO, Barnhart MI (1989) Stimulated effects upon megakaryocytopoiesis and pulmonary-platelet interactions. Gen Physiol Biophys 8:611–631
Weingand K, Brown G, Hall R et al. (1996) Harmonisation of animal clinical pathology testing in toxicity and safety studies. Fund Appl Toxicol 29:198–201
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Esch, E., Salemink, P., Roelofs, M. et al. Canine bone marrow cytology as a means of supporting peripheral blood changes. Comparative Haematology International 6, 242–245 (1996). https://doi.org/10.1007/BF00378118
Issue Date:
DOI: https://doi.org/10.1007/BF00378118